Ronald L Korn
Overview
Explore the profile of Ronald L Korn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
1381
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Korn R, Von Hoff D, Borad M, Renschler M, McGovern D, Bay R, et al.
Cancer Imaging
. 2017 Aug;
17(1):23.
PMID: 28774338
Background: Positron emission tomography (PET) is poised to become a useful imaging modality in staging and evaluating therapeutic responses in patients with metastatic pancreatic cancer (mPC). This analysis from a...
12.
Ramanathan R, Korn R, Raghunand N, Sachdev J, Newbold R, Jameson G, et al.
Clin Cancer Res
. 2017 Feb;
23(14):3638-3648.
PMID: 28159813
To determine whether deposition characteristics of ferumoxytol (FMX) iron nanoparticles in tumors, identified by quantitative MRI, may predict tumor lesion response to nanoliposomal irinotecan (nal-IRI). Eligible patients with previously treated...
13.
Yamamoto S, Huang D, Du L, Korn R, Jamshidi N, Burnette B, et al.
Radiology
. 2016 Apr;
280(1):261-70.
PMID: 27082783
Purpose To investigate whether non-small cell lung cancer (NSCLC) tumors that express high normalized maximum standardized uptake value (SUVmax) are associated with a more epithelial-mesenchymal transition (EMT)-like phenotype. Materials and...
14.
Jamshidi N, Jonasch E, Zapala M, Korn R, Brooks J, Ljungberg B, et al.
Eur Radiol
. 2015 Nov;
26(8):2798-807.
PMID: 26560727
Objectives: To characterize a radiogenomic risk score (RRS), a previously defined biomarker, and to evaluate its potential for stratifying radiological progression-free survival (rPFS) in patients with metastatic renal cell carcinoma...
15.
Jamshidi N, Jonasch E, Zapala M, Korn R, Aganovic L, Zhao H, et al.
Radiology
. 2015 Sep;
277(1):114-23.
PMID: 26402495
Purpose: To evaluate the feasibility of constructing radiogenomic-based surrogates of molecular assays (SOMAs) in patients with clear-cell renal cell carcinoma (CCRCC) by using data extracted from a single computed tomographic...
16.
Picozzi V, Ramanathan R, Lowery M, Ocean A, Mitchel E, ONeil B, et al.
Eur J Cancer
. 2015 Jul;
51(14):1857-64.
PMID: 26187510
Background: For patients with metastatic pancreatic adenocarcinoma, there are no approved or established treatments beyond the 2nd line. A Phase Ib study of fractionated radioimmunotherapy was undertaken in this setting,...
17.
Banerjee S, Wang D, Kim H, Sirlin C, Chan M, Korn R, et al.
Hepatology
. 2015 May;
62(3):792-800.
PMID: 25930992
Unlabelled: Microvascular invasion (MVI) in hepatocellular carcinoma (HCC) is an independent predictor of poor outcomes subsequent to surgical resection or liver transplantation (LT); however, MVI currently cannot be adequately determined...
18.
Weiss G, Ganeshan B, Miles K, Campbell D, Cheung P, Frank S, et al.
PLoS One
. 2014 Jul;
9(7):e100244.
PMID: 24987838
Background: Non-invasive characterization of a tumor's molecular features could enhance treatment management. Quantitative computed tomography (CT) based texture analysis (QTA) has been used to derive tumor heterogeneity information, and the...
19.
Yamamoto S, Korn R, Oklu R, Migdal C, Gotway M, Weiss G, et al.
Radiology
. 2014 Jun;
272(2):568-76.
PMID: 24885982
Purpose: To present a radiogenomic computed tomographic (CT) characterization of anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer (NSCLC) (ALK+). Materials And Methods: In this HIPAA-compliant institutional review board-approved retrospective...
20.
Korn R, Crowley J
Clin Cancer Res
. 2013 May;
19(10):2607-12.
PMID: 23669420
Progression-free survival (PFS) is increasingly used as an important and even a primary endpoint in randomized cancer clinical trials in the evaluation of patients with solid tumors for both practical...